Fig. 4From: Uptake of new antidiabetic medicines in 11 European countriesCorrelation between the ratio (2011 compared to 2007) of intensity of prescribing policy for all antidiabetic medicines and volume market share of incretin-based medicines (DDP-4 inhibitors and GLP-1 receptor agonists) in 2011Back to article page